Novo Holdings A/S - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$20,510,490
+12.2%
1,001,000
+8.8%
1.52%
+7.3%
Q2 2023$18,280,400
+16.0%
920,0000.0%1.41%
+35.9%
Q1 2023$15,759,600
-5.3%
920,000
+8.2%
1.04%
+0.1%
Q4 2022$16,634,500
+64.7%
850,000
+34.3%
1.04%
+115.6%
Q3 2022$10,100,000
+16.0%
632,8220.0%0.48%
+12.4%
Q2 2022$8,708,000
-10.4%
632,822
+3.3%
0.43%
-16.4%
Q1 2022$9,719,000
-27.4%
612,8220.0%0.51%
-19.0%
Q4 2021$13,378,000
-16.2%
612,822
+14.7%
0.63%
-23.4%
Q3 2021$15,964,000534,0850.83%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders